Lululab, an AI beauty and healthcare company using skin data, said it would jointly target the Southeast Asian digital healthcare market with a Vietnamese partner.

The company signed a memorandum of understanding with Hanoi Medical University (HMU) to develop an AI analytic solution for skin disease through joint research and establish AI medical infrastructure in Vietnam. Lululab CEO Choe Yong-joon, HMU President Nguyen Huu Tu, and other officials from the two sides attended the signing ceremony in Vietnam last Friday.

The two sides will begin with joint research to develop an AI analytical solution for skin diseases typical in Vietnam.

The research will be based on Lululab’s AI algorithm for skin analysis. Through cooperation, the two sides will develop an AI solution for diagnosing various skin problems using HMU’s data and skin disease diagnosis.

The company aims to launch an AI analysis solution on skin disease and introduce it to Vietnam’s medical sites, mainly in local dermatology clinics.

“Due to the lack of medical infrastructures, such as the medical workforce, in Vietnam, there’s a need for technology which can supplement existing diagnostic methods,” said Lululab CEO Choe Yong-joon. “Lululab will launch an AI solution for major skin problems and supply it across Vietnam through the hospital network established with HMU.”

Lululab will also provide a training service on the latest technology in AI medical field. The company said this is meaningful by creating a virtuous cycle ecosystem by training talented staff to adapt to the future AI medical infrastructure that the two institutions would build.

The two institutions will also develop a cosmetic recommendation algorithm that suits the Vietnam market and ingredients and finished products of cosmetics and health functional foods.